MorphoSys Unit to Use Thermo Fisher's Fluorescent Dyes to Develop Reagents | GenomeWeb
NEW YORK (GenomeWeb News) — Thermo Fisher Scientific today said synthetic antibody developer AbD Serotec will use its DyLight dyes as part of a collaborative agreement to develop a series of fluorescent reagents.
 
Under the agreement, Serotec, a subsidiary of MorphoSys, will develop and sell the resulting products through its catalog, Thermo said.
 
Thermo said its DyLight products are water soluble and provide high fluorescent intensity in various applications.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.